Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Burstein

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
The effect of garlic supplements on the pharmacokinetics of saquinavirStephen C Piscitelli, Aaron H Burstein, Nada Welden, et al.
The Journal of Bone and Joint Surgery. American Volume|March 21, 2018
Early Clinical and Radiographic Outcomes of Trabecular Metal Total Ankle Replacement Using a Transfibular ApproachAlexej Barg, Clayton C Bettin, Albert H Burstein, et al.
Journal of Biomechanical Engineering|November 1, 1981
A method of analyzing the three-dimensional stiffness properties of the intact human lumbar spineJ M Laborde, A H Burstein, K Song, et al.
Molecular Pharmacology|April 16, 2003
Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acidJilin Liu, Hui Li, Sumner H Burstein, et al.
Pharmacotherapy|March 20, 2001
Phenylacetate pharmacokinetics based on iterative two-stage population analysisA H Burstein, E Reed, A C Tompkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Metabolism and disposition of a gamma-aminobutyric acid type A receptor partial agonist in humansChristopher L Shaffer, Mithat Gunduz, Alfin D Vaz, et al.
Electroencephalography and Clinical Neurophysiology|September 1, 1972
A neuromuscular testing deviceE Bahniuk, A H Burstein, V H Frankel, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Harnessing combination therapy: Current treatments, recent advancements, and future directions in Alzheimer's diseaseHoward M Fillit, Jacques Touchon, Bruno Vellas, et al.
The Journal of Prevention of Alzheimer'S Disease|April 5, 2018
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's DiseaseA H Burstein, M Sabbagh, R Andrews, et al.
Lancet (London, England)|February 22, 2000
Indinavir concentrations and St John's wortS C Piscitelli, A H Burstein, D Chaitt, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
The effect of garlic supplements on the pharmacokinetics of saquinavirStephen C Piscitelli, Aaron H Burstein, Nada Welden, et al.
The Journal of Bone and Joint Surgery. American Volume|March 21, 2018
Early Clinical and Radiographic Outcomes of Trabecular Metal Total Ankle Replacement Using a Transfibular ApproachAlexej Barg, Clayton C Bettin, Albert H Burstein, et al.
Journal of Biomechanical Engineering|November 1, 1981
A method of analyzing the three-dimensional stiffness properties of the intact human lumbar spineJ M Laborde, A H Burstein, K Song, et al.
Molecular Pharmacology|April 16, 2003
Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acidJilin Liu, Hui Li, Sumner H Burstein, et al.
Pharmacotherapy|March 20, 2001
Phenylacetate pharmacokinetics based on iterative two-stage population analysisA H Burstein, E Reed, A C Tompkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Metabolism and disposition of a gamma-aminobutyric acid type A receptor partial agonist in humansChristopher L Shaffer, Mithat Gunduz, Alfin D Vaz, et al.
Electroencephalography and Clinical Neurophysiology|September 1, 1972
A neuromuscular testing deviceE Bahniuk, A H Burstein, V H Frankel, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Harnessing combination therapy: Current treatments, recent advancements, and future directions in Alzheimer's diseaseHoward M Fillit, Jacques Touchon, Bruno Vellas, et al.
The Journal of Prevention of Alzheimer'S Disease|April 5, 2018
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's DiseaseA H Burstein, M Sabbagh, R Andrews, et al.
Lancet (London, England)|February 22, 2000
Indinavir concentrations and St John's wortS C Piscitelli, A H Burstein, D Chaitt, et al.
Pageof 20